Eurofins Scientific SE (ERFSF)
USD 49.72
(0.0%)
USD 49.72
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 310.2 Million EUR | -49.16% |
| 2022 | 610.2 Million EUR | -22.03% |
| 2021 | 782.6 Million EUR | 45.09% |
| 2020 | 539.4 Million EUR | 176.33% |
| 2019 | 195.2 Million EUR | -12.82% |
| 2018 | 223.9 Million EUR | 3.29% |
| 2017 | 216.77 Million EUR | 24.58% |
| 2016 | 173.99 Million EUR | 99.27% |
| 2015 | 87.31 Million EUR | 10.38% |
| 2014 | 79.1 Million EUR | 9.59% |
| 2013 | 72.18 Million EUR | 9.49% |
| 2012 | 65.92 Million EUR | 18.98% |
| 2011 | 55.4 Million EUR | 136.78% |
| 2010 | 23.4 Million EUR | 307.35% |
| 2009 | -11.28 Million EUR | -163.72% |
| 2008 | 17.71 Million EUR | 0.41% |
| 2007 | 17.63 Million EUR | 0.74% |
| 2006 | 17.5 Million EUR | 41.27% |
| 2005 | 12.39 Million EUR | 57.95% |
| 2004 | 7.84 Million EUR | 386.12% |
| 2003 | 1.61 Million EUR | 1061.15% |
| 2002 | 139 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 220.7 Million EUR | 0.0% |
| 2023 Q2 | 151.5 Million EUR | 0.0% |
| 2023 FY | 310.2 Million EUR | -49.16% |
| 2023 Q4 | 158.8 Million EUR | 0.0% |
| 2022 Q4 | 300.5 Million EUR | 0.0% |
| 2022 FY | 610.2 Million EUR | -22.03% |
| 2022 Q2 | 309.7 Million EUR | 0.0% |
| 2021 FY | 782.6 Million EUR | 45.09% |
| 2021 Q2 | 415.5 Million EUR | 0.0% |
| 2021 Q4 | 367.1 Million EUR | 0.0% |
| 2020 Q4 | 444.8 Million EUR | 0.0% |
| 2020 FY | 539.4 Million EUR | 176.33% |
| 2020 Q2 | 94.7 Million EUR | 0.0% |
| 2019 Q2 | 58.87 Million EUR | 0.0% |
| 2019 FY | 195.2 Million EUR | -12.82% |
| 2019 Q4 | 136.32 Million EUR | 0.0% |
| 2018 Q2 | 66.9 Million EUR | 0.0% |
| 2018 FY | 223.9 Million EUR | 3.29% |
| 2018 Q4 | 108.39 Million EUR | 0.0% |
| 2017 Q2 | 56.73 Million EUR | 0.0% |
| 2017 Q4 | 122.7 Million EUR | 0.0% |
| 2017 FY | 216.77 Million EUR | 24.58% |
| 2016 Q2 | 43.22 Million EUR | 0.0% |
| 2016 Q4 | 95.15 Million EUR | 0.0% |
| 2016 FY | 173.99 Million EUR | 99.27% |
| 2015 FY | 87.31 Million EUR | 10.38% |
| 2015 Q2 | 30.27 Million EUR | 0.0% |
| 2015 Q4 | 26.08 Million EUR | 0.0% |
| 2014 FY | 79.1 Million EUR | 9.59% |
| 2014 Q4 | 55.39 Million EUR | 0.0% |
| 2014 Q2 | 22.58 Million EUR | 0.0% |
| 2013 Q4 | 30.61 Million EUR | 0.0% |
| 2013 Q2 | 22.52 Million EUR | 0.0% |
| 2013 FY | 72.18 Million EUR | 9.49% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | 65.92 Million EUR | 18.98% |
| 2011 Q1 | 1.67 Million EUR | -86.36% |
| 2011 Q4 | 23.45 Million EUR | 25.17% |
| 2011 Q2 | 12.65 Million EUR | 658.02% |
| 2011 Q3 | 18.73 Million EUR | 48.02% |
| 2011 FY | 55.4 Million EUR | 136.78% |
| 2010 Q1 | -2.54 Million EUR | 85.18% |
| 2010 Q2 | 6.3 Million EUR | 347.35% |
| 2010 Q3 | 15.84 Million EUR | 151.43% |
| 2010 Q4 | 12.24 Million EUR | -22.7% |
| 2010 FY | 23.4 Million EUR | 307.35% |
| 2009 FY | -11.28 Million EUR | -163.72% |
| 2009 Q4 | -17.18 Million EUR | -669.88% |
| 2009 Q3 | 3.01 Million EUR | 1951.02% |
| 2009 Q1 | -3.02 Million EUR | 0.0% |
| 2009 Q2 | 147 Thousand EUR | 104.85% |
| 2008 FY | 17.71 Million EUR | 0.41% |
| 2007 FY | 17.63 Million EUR | 0.74% |
| 2006 FY | 17.5 Million EUR | 41.27% |
| 2005 FY | 12.39 Million EUR | 57.95% |
| 2004 FY | 7.84 Million EUR | 386.12% |
| 2003 FY | 1.61 Million EUR | 1061.15% |
| 2002 FY | 139 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | 22100.0% |
| Arrayit Corporation | -3.31 Million USD | 9455.79% |
| Atlantic International Corp. | -5.62 Million USD | 5612.128% |
| Biocept, Inc. | -32.08 Million USD | 1066.747% |
| Bioqual, Inc. | 483.48 Thousand USD | -64059.708% |
| CardioGenics Holdings Inc | -1.91 Million USD | 16287.242% |
| DermTech, Inc. | -100.88 Million USD | 407.47% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 84.68% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 1536.478% |
| iMD Companies, Inc. | -200.63 Thousand USD | 154708.345% |
| IDenta Corp. | 14.64 Thousand USD | -2118173.696% |
| Interpace Biosciences, Inc. | 802 Thousand USD | -38578.304% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | -801678.283% |
| InVitro International | 1553.00 USD | -19974143.4% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 3710.335% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 533896.806% |
| Medical Imaging Corp. | -3.02 Million USD | 10361.248% |
| NovelStem International Corp. | -4.18 Million USD | 7508.115% |
| Optigenex Inc. | -2.89 Million USD | 10804.82% |
| PharmChem, Inc. | 845.1 Thousand USD | -36605.628% |
| Proteome Sciences plc | -2.44 Million USD | 12797.503% |
| Response Genetics, Inc | -20.18 Million USD | 1636.861% |
| Rennova Health, Inc. | -3.29 Million USD | 9519.824% |
| RushNet, Inc. | -607.02 Thousand USD | 51201.432% |
| ScreenPro Security Inc. | -2.24 Million USD | 13894.226% |
| Stella Diagnostics Inc. | -5.7 Million USD | 5535.023% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 2817.388% |
| Todos Medical Ltd. | -24.99 Million USD | 1341.098% |